Hiroshi Yamamoto

TL;DR: It is suggested that PFAA profiling has great potential for improving cancer screening and diagnosis and understanding disease pathogenesis, which involves a relatively simple plasma assay and imposes a lower physical burden on subjects when compared to existing screening methods.

TL;DR: Even after adjusting for commonly accepted multiple risk factors, these models can predict future development of diabetes, metabolic syndrome, and dyslipidemia.

TL;DR: This study shows that plasma amino acid profiling will be a potential screening tool for NSCLC patients regardless of disease stage or histological type.

TL;DR: The results suggest that AJvW‐2 is a potent inhibitor of the GPIb‐vWF interaction and a potential novel antithrombotic agent with lower bleeding risk than GPIIb/IIIa antagonists.

TL;DR: The findings suggest that the PFAA profile of PC was significantly different from that of HC, and this index is a promising biomarker for screening and diagnosis of PC.